Factors Associated With Discussions of Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex With Men

REFERENCES

1. 1.↵
   Pre-Exposure Prophylaxis (PrEP). Centers for Disease Control and Prevention website. www.cdc.gov/hiv/risk/prep/. Updated November 1, 2018. Accessed May 10, 2019.
2. 2.↵
   1. Grant RM,
   2. Lama JR,
   3. Anderson PL,
   4. et al.

   Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587-2599.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Grohskopf LA,
   2. Chillag KL,
   3. Gvetadze R,
   4. et al.

   Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Aquir Immune Defic Syndr. 2013 Sep;64(1):79-86. doi: 10.1097/QAI.0b013e31828ece33.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Hosek SG,
   2. Siberry G,
   3. Bell M,
   4. et al.

   The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Aquir Immune Defic Syndr. 2013 Apr 1;62(4):447-456. doi: 10.1097/QAI.0b013e3182801081.

   OpenUrlCrossRefPubMed
5. 5.↵
   FDA approves first drug for reducing the risk of sexually acquired HIV infection. AIDS Info. U.S. Department of Health and Human Services. aidsinfo.nih.gov/news/1254/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection. Published July 16, 2012. Accessed February 13, 2018.
6. 6.↵
   Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization. www.who.int/hiv/pub/guidelines/arv2013/en/. Published June 2013. Accessed February 13, 2018.
7. 7.↵
   Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update. A clinical practice guideline. Centers for Disease Control and Prevention. www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Accessed May 12, 2019.
8. 8.↵
   1. Owens DK,
   2. Davidson KW,
   3. Krist AH,
   4. et al.

   US Preventive Services Task Force, Owens DK, , Davidson KW, , Krist AH, , et al. Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 Jun 11;321(22):2203-2213. doi: 10.1001/jama.2019.6390.

   OpenUrlCrossRef
9. 9.↵
   HIV in the United States by Region. Centers for Disease Control and Prevention. www.cdc.gov/hiv/statistics/overview/geographicdistribution.html. Updated November 27, 2018. Accessed February 13, 2018.
10. 10.↵
    2015 STD/HIV Surveillance Report. Louisiana Department of Health Office of Public Health. http://ldh.la.gov/assets/oph/HIVSTD/2015_STDHIV_SurveillanceReport.pdf. Accessed March 18, 2018.
11. 11.↵
    1. Levin J

    . FTC/TDF (Truvada) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: 2012-2015. www.natap.org/2016/IAC/IAC_17.htm. Published July 2016. Accessed 13 February 13, 2018.
12. 12.↵
    1. Banerjee A,
    2. Sanyal D.

    Dynamics of doctor-patient relationship: a cross-sectional study on concordance, trust, and patient enablement. J Family Community Med. 2012 Jan;19(1):12-19. doi: 10.4103/2230-8229.94006.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Petroll AE,
    2. Walsh JL,
    3. Owczarzak JL,
    4. McAuliffe TL,
    5. Bogart LM,
    6. Kelly JA

    . PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017 May;21(5):1256-1267. doi: 10.1007/s10461-016-1625-1.

    OpenUrlCrossRef
14. 14.↵
    1. Krakower D,
    2. Ware N,
    3. Mitty JA,
    4. Maloney K,
    5. Mayer KH

    . HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014 Sep;18(9):1712-1721. doi: 10.1007/s10461-014-0839-3.

    OpenUrlCrossRefPubMed
15. 15.↵
    PrEP’D AF. Los Angeles LGBT Center. prephere.org/. Accessed June 17, 2018.
16. 16.↵
    Louisiana Department of Health & Hospitals Funded Categories. Centers for Disease Control and Prevention. www.cdc.gov/hiv/pdf/research/demonstration/executive_summaries/cdc-hiv-pride-Louisiana.pdf. Accessed March 15, 2018.
17. 17.↵
    Project PrIDE. Centers for Disease Control and Prevention. www.cdc.gov/hiv/research/demonstration/projectpride.html. Accessed March 15, 2018.
18. 18.↵
    1. Gallo A.

    Despite innovations in treatment, HIV rates still high, including in Baton Rouge and New Orleans. The Advocate. December 30, 2015. www.theadvocate.com/baton_rouge/news/article_53df0406-6084-553c-baef-698becaa3ac9.html. Accessed March 15, 2018.
19. 19.↵
    1. Curth K.

    There's a new way to fight the HIV epidemic in New Orleans. FOX8. February 4, 2017. Updated August 12, 2017. www.fox8live.com/story/34424431/theres-a-new-way-to-fight-the-hiv-epidemic-in-new-orleans. Accessed March 18, 2018.
20. 20.↵
    QuickFacts: New Orleans city, Louisiana. United States Census Bureau. www.census.gov/quickfacts/neworleanscitylouisiana. Published July 1, 2018. Accessed May 10, 2019.